What is PXS.L's gross margin?

Provexis (PXS.L) has a gross margin of 51% and a net margin of -58%.

What is PXS.L's P/E ratio?

Track Provexis (PXS.L) P/E ratio, ROE, and valuation metrics over time.

Where can I see PXS.L's full financials?

See Provexis (PXS.L) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Provexis (PXS.L) Financials — Revenue, Earnings, Cash Flow

£0.86 ($0.01)

-0.10 (-10.42%)

Weekly Expected Move ±9.5%

£1 £1 £1 £1 £1

LSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 40 · £22.5M mcap · 1.81B float · 0.056% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

📊 Key Metrics

TTM

£2M

Revenue

+156.6% YoY

£-1M

Net Income

-70.5% YoY

£-1M

Free Cash Flow

+27.6% YoY

51.2%

Gross Margin

-117.6%

Op. Margin

-57.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-83.5%

ROA-111.8%

ROIC-141.0%

Valuation

P/E-44.8

P/B20.4

EV/EBITDA-15.7

Leverage

Debt/Equity0.00

Current Ratio4.08

Interest Cov.0.0x

Quality Scores

Piotroski F2/9

Altman Z-3.27

Beneish M-3.71